Dan Rosenbaum serves as the Chief Executive Officer of NattoPharma. He has extensive experience in strategy development and implementation, general management, finance, and business development. A senior leader with global, multi-cultural background and experience, he has a successful track record of driving operational excellence and building motivated, high-performance organizations. Prior to joining NattoPharma, he served in several senior management roles at FMC Corporation, including: General Manager FMC Health & Nutrition – nutraceuticals and pharmaceutical divisions; global director, Ag Products Professional Solutions division; and in Brazil as both CFO and director of marketing for FMC Quimica do Brasil. Dan earned an M.B.A. from the Tuck School of Business Administration, Dartmouth College; and a B.A. in Economics, with distinction, and a B.A. Fine Arts, Sculpture, both from Cornell University.
Dr. Hogne Vik serves as the Chief Medical Officer. Dr. Vik, a medical doctor by training, has more than 30 years of experience in medical, pharmaceutical, dietary supplement and research industries. As global VP in product development in Nycomed Dr. Vik was one of the main forces behind the development and market entrance of VisiPaque. Following Nycomed, Vik was instrumental in bringing Tonalin (CLA) to the European and US market, as part of Natural ASA. Additionally, he was one of the key executives in the management team of Pronova BioPharma securing the US and Japanese market entrance of Omacor/Lovaza. Most recently, Dr. Vik has been the driving force behind the documentation program securing the current marketing position of Superba Krill Oil developed and manufactured by Aker BioMarine Antarctic.
Anne Bjørnebye Vik
Senior Vice President R&D and Regulatory Affairs
Anne has a PhD in biochemistry from University of Oslo (UiO), and has worked in research in Oslo Cancer Hospital for 9 years. She was with Nycomed, a pharmaceutical company, for 16 years working nationally and internationally with pharmaceuticals and diagnostics, as well as working for 1 year with research strategy for the Norwegian Research Council. As a scientific officer in a skincare company, she managed a start-up biotech company working in animal genomics, and has worked with vitamin K2 since 2006, responsible for research and regulatory affairs. In addition to her PhD, she has an MBA from the Norwegian School of Economics.
Senior Vice President Sales & Marketing US and Global Accounts
Eric Anderson has been a member of the natural products industry for more than 20 years, during which time he was involved in the introduction of several successful novel ingredients, including Chitosan, CLA and MK-7 Natural Vitamin K2. Most recently, he was VP Sales and Marketing for Aker BioMarine Antarctic US, where he was responsible for establishing and staffing the company’s North American offices, with an emphasis on promoting Superba™ brand krill oil.
Director of Communications
Having previously served as the Editor-in-Chief of VRM Media, publisher of b2b magazines for the natural health and dietary supplement industries, Kate has an extensive understanding of the retail and alternative practitioner markets, as well as the supply side of the natural products industry. With nine additional years of publishing experience, seven in B2B and two in medical texts, Kate was also a freelance journalist who developed content for the Multiple Sclerosis Association.
Rudi De Man
VP Sales and Business Development
Rudi De Man serves as Vice President of Sales and Business Development of NattoPharma ASA, responsible for Europe and Asia. Prior to joining NattoPharma, he held sales leadership and business development roles in the FMC Health and Nutrition division. During his 19-year tenure at FMC, De Man served in a variety of sales roles, acquiring international sales experience and an extensive knowledge of the Food Ingredients and Pharmaceutical & Nutraceutical business. His most recent position was Sales Director Europe, Middle East, Africa, and Eastern Europe for Food Stabilizers and Colors, where he was responsible for managing the Food and Personal Care business. De Man has a degree in Biochemistry.
VP, Global Development and Regulatory
William Sommer joined the company in 2015 to serve as Vice President, Global Development and Regulatory. Prior to joining NattoPharma, Mr. Sommer led the global formulations group at FMC Chemical Corporation. A chemical engineer by training, Mr. Sommer has more than 20 years experience working in development, specialty chemical manufacturing, and regulated industries.
1363 Høvik, Norway
Tel: (+47) 40 00 90 08
NattoPharma USA, Inc.
(North American Subsidiary)
328 Amboy Avenue
Metuchen, NJ 08840, USA
Tel: (+1) 609-454-2992
To contact staff members of NattoPharma, address your email using the staff member's first name along with @nattopharma.com